Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Mar 16, 2026; 18(3): 116958
Published online Mar 16, 2026. doi: 10.4253/wjge.v18.i3.116958
Published online Mar 16, 2026. doi: 10.4253/wjge.v18.i3.116958
Figure 1 Serum cytokine levels before and after Helicobacter pylori eradication in patients with gastritis and duodenal ulcer.
A: Interleukin (IL)-1α; B: IL-1β; C: IL-2; D: IL-6; E: IL-8; F: IL-10; G: IL-12p70; H: IL-23; I: Interferon gamma; J: Tumor necrosis factor-alpha. Boxes represent the median and interquartile range, with whiskers indicating minimum and maximum values; individual data points are shown. Gastritis (n = 33) and duodenal ulcer (n = 21). Statistical comparisons were performed using the Mann-Whitney U test or Wilcoxon signed-rank test, as appropriate, with P-values adjusted for multiple comparisons using the false discovery rate. aP < 0.05; bP < 0.01; cP < 0.001. GA: Gastritis; DU: Duodenal ulcer; IL: Interleukin; TNF-α: Tumor necrosis factor-alpha; IFN-γ: Interferon gamma.
- Citation: de Melo FF, Lemos FFB, Leal RAOS, Rocha GA, de Magalhães Queiroz DM. Helicobacter pylori eradication is associated with systemic anti-inflammatory shift in duodenal ulcer patients compared to those with gastritis. World J Gastrointest Endosc 2026; 18(3): 116958
- URL: https://www.wjgnet.com/1948-5190/full/v18/i3/116958.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i3.116958
